Document Detail

Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
MedLine Citation:
PMID:  19131449     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The aim of this study was to identify key factors on admission predicting the development of complicated parapneumonic effusion or empyema in patients admitted with community-acquired pneumonia. METHODS: A prospective observational study of patients admitted with community-acquired pneumonia in NHS Lothian, UK, was conducted. Multivariate regression analyses were used to evaluate factors that could predict the development of complicated parapneumonic effusion or empyema, including admission demographics, clinical features, laboratory tests and pneumonia-specific (Pneumonia Severity Index (PSI), CURB65 (New onset confusion, urea >7 mmol/l, Respiratory rate > or = 30 breaths/min, Systolic blood pressure < 90 mm Hg and/or diastolic blood pressure < or = 60 mm Hg and age > or = 65 years) and CRB65 (New onset confusion, Respiratory rate > or = 30 breaths/min, Systolic blood pressure <90 mm Hg and/or diastolic blood pressure < or = 60 mm Hg and age > or = 65 years)) and generic sepsis scoring systems (APACHE II (Acute Physiology and Chronic Health Evaluation II), SEWS (standardised early warning score) and systemic inflammatory response syndrome (SIRS)). RESULTS: 1269 patients were included in the study and 92 patients (7.2%) developed complicated parapneumonic effusion or empyema. The pneumonia-specific and generic sepsis scoring systems had no value in predicting complicated parapneumonic effusion or empyema. Multivariate logistic regression identified albumin <30 g/l adjusted odds ratio (AOR) 4.55 (95% CI 2.45 to 8.45, p < 0.0001), sodium <130 mmol/l AOR 2.70 (1.55 to 4.70, p = 0.0005), platelet count >400 x 10(9)/l AOR 4.09 (2.21 to 7.54, p < 0.0001), C-reactive protein >100 mg/l AOR 15.7 (3.69 to 66.9, p < 0.0001) and a history of alcohol abuse AOR 4.28 (1.87 to 9.82, p = 0.0006) or intravenous drug use AOR 2.82 (1.09 to 7.30, p = 0.03) as independently associated with development of complicated parapneumonic effusion or empyema. A history of chronic obstructive pulmonary disease was associated with decreased risk, AOR 0.18 (0.06 to 0.53, p = 0.002). A 6-point scoring system using these combined variables had good discriminatory value: area under the receiver operator characteristic curve (AUC) 0.84 (95% CI 0.81 to 0.86, p < 0.0001). CONCLUSION: This study has identified seven clinical factors predicting the development of complicated parapneumonic effusion or empyema. Independent validation is needed.
J D Chalmers; A Singanayagam; M P Murray; C Scally; A Fawzi; A T Hill
Related Documents :
18174769 - Relationship between morning hypertension identified by home blood pressure monitoring ...
17890969 - Effects of isometric handgrip training among people medicated for hypertension: a multi...
23147329 - Hemodynamic changes comparing lidocaine hcl with epinephrine and articaine hcl with epi...
1684749 - The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
21769299 - Explicit control of implicit responses: simple directives can alter iat performance.
24565189 - Effect of normal saline administration on circulation stability during general anesthes...
7900839 - Pressure dependency of canine intrarenal blood flow within the range of autoregulation.
7397409 - Effects of antihypertensive drug therapy on the morphology and mechanics of resistance ...
498709 - Interindividual variation in kinetics of infused epinephrine.
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't     Date:  2009-01-08
Journal Detail:
Title:  Thorax     Volume:  64     ISSN:  1468-3296     ISO Abbreviation:  Thorax     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-29     Completed Date:  2009-08-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  England    
Other Details:
Languages:  eng     Pagination:  592-7     Citation Subset:  IM    
Department of Respiratory Medicine, Royal Infirmary of Edinburgh, 51 Little France Crescent, Old Dalkeith Road, Edinburgh EH16 4SA, Scotland, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood
Community-Acquired Infections / complications
Empyema, Pleural / microbiology*
Epidemiologic Methods
Middle Aged
Pleural Effusion / microbiology*
Pneumonia, Bacterial / complications*
Grant Support
//Medical Research Council
Reg. No./Substance:
0/Biological Markers
Comment In:
Thorax. 2009 Jul;64(7):556-8   [PMID:  19561275 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
Next Document:  Heterogeneity of asthma according to blood inflammatory patterns.